Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia
- 16 July 2009
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (10), 1415-1426
- https://doi.org/10.3324/haematol.2008.003129
Abstract
Thalassemia major can be cured with allogeneic hematopoietic stem cell transplantation. Persistent mixed chimerism develops in around 10% of transplanted thalassemic patients, but the biological mechanisms underlying this phenomenon are poorly understood. The presence of interleukin-10-producing T cells in the peripheral blood of eight patients with persistent mixed chimerism and five with full donor chimerism was investigated. A detailed characterization was then performed, by T-cell cloning, of the effector and regulatory T-cell repertoire of one patient with persistent mixed chimerism, who developed stable split erythroid/lymphoid chimerism after a hematopoietic stem cell transplant from an HLA-matched unrelated donor. Higher levels of interleukin-10 were produced by peripheral blood mononuclear cells from patients with persistent mixed chimerism than by the same cells from patients with complete donor chimerism or normal donors. T-cell clones of both host and donor origin could be isolated from the peripheral blood of one, selected patient with persistent mixed chimerism. Together with effector T-cell clones reactive against host or donor alloantigens, regulatory T-cell clones with a cytokine secretion profile typical of type 1 regulatory cells were identified at high frequencies. Type 1 regulatory cell clones, of both donor and host origin, were able to inhibit the function of effector T cells of either donor or host origin in vitro. Overall these results suggest that interleukin-10 and type 1 regulatory cells are associated with persistent mixed chimerism and may play an important role in sustaining long-term tolerance in vivo. These data provide new insights into the mechanisms of peripheral tolerance in chimeric patients and support the use of cellular therapy with regulatory T cells following hematopoietic stem cell transplantation.Keywords
This publication has 52 references indexed in Scilit:
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemiaBlood, 2008
- Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humansNature Reviews Immunology, 2007
- Delayed attainment of full donor chimaerism following alemtuzumab‐based reduced‐intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomesBritish Journal of Haematology, 2007
- CD4+CD25+ Regulatory T Cells and Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host diseaseBone Marrow Transplantation, 2005
- Regulatory T cells under scrutinyNature Reviews Immunology, 2003
- Lymphokine Production by Human T Cells in Disease StatesAnnual Review of Immunology, 1994
- Marrow Transplantation in Patients with Thalassemia Responsive to Iron Chelation TherapyNew England Journal of Medicine, 1993
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989